Department of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Rheumatology Division, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Cancer Med. 2020 Jul;9(13):4836-4849. doi: 10.1002/cam4.3111. Epub 2020 May 11.
Previous studies have reported a close relationship between malignant mesothelioma (MM) and the immune matricial microenvironment (IMM). One of the major problems in these studies is the lack of adequate adjustment for potential confounders. Therefore, the aim of this study was to identify and quantify risk factors such as IMM and various tumor characteristics and their association with the subtype of MM and survival.
We examined IMM and other tumor markers in tumor tissues from 82 patients with MM. These markers were evaluated by histochemistry, immunohistochemistry, immunofluorescence, and morphometry. Logistic regression analysis, cluster analysis, and Cox regression analysis were performed.
Hierarchical cluster analysis revealed two clusters of MM that were independent of clinicopathologic features. The high-risk cluster included MM with high tumor cellularity, high type V collagen (Col V) fiber density, and low CD8 T lymphocyte density in the IMM. Our results showed that the risk of death was increased for patients with MM with high tumor cellularity (OR = 1.63, 95% CI = 1.29-2.89, P = .02), overexpression of Col V (OR = 2.60, 95% CI = 0.98-6.84, P = .04), and decreased CD8 T lymphocytes (OR = 1.001, 95% CI = 0.995-1.007, P = .008). The hazard ratio for the high-risk cluster was 2.19 (95% CI = 0.54-3.03, P < .01) for mortality from MM at 40 months.
Morphometric analysis of Col V, CD8 T lymphocytes, and tumor cellularity can be used to identify patients with high risk of death from MM.
先前的研究报告称恶性间皮瘤(MM)与免疫基质微环境(IMM)密切相关。这些研究的主要问题之一是缺乏对潜在混杂因素的充分调整。因此,本研究旨在确定和量化 IMM 和各种肿瘤特征等风险因素及其与 MM 亚型和生存的关系。
我们检查了 82 名 MM 患者肿瘤组织中的 IMM 和其他肿瘤标志物。这些标志物通过组织化学、免疫组织化学、免疫荧光和形态计量学进行评估。进行了逻辑回归分析、聚类分析和 Cox 回归分析。
层次聚类分析显示,MM 存在两个独立于临床病理特征的聚类。高危聚类包括 IMM 中肿瘤细胞密度高、V 型胶原(Col V)纤维密度高和 CD8 T 淋巴细胞密度低的 MM。结果表明,肿瘤细胞密度高(OR=1.63,95%CI=1.29-2.89,P=0.02)、Col V 过表达(OR=2.60,95%CI=0.98-6.84,P=0.04)和 CD8 T 淋巴细胞减少(OR=1.001,95%CI=0.995-1.007,P=0.008)的 MM 患者死亡风险增加。高危聚类的危险比为 2.19(95%CI=0.54-3.03,P<0.01),40 个月时 MM 死亡率为 2.19。
Col V、CD8 T 淋巴细胞和肿瘤细胞计数的形态计量分析可用于识别 MM 死亡风险较高的患者。